With enrollment finished in the Phase III trial testing its prostate cancer drug, GPC Biotech AG raised €36.2 million ($43M) in a private placement with a pair of German investment firms owned by the family of Dietmar Hopp, who founded the world’s largest business software concern, SAP AG. (BioWorld Today)